3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
84
Colorectal Neoplasms
42
Rectal Neoplasms
40
Carcinoma, Non-Small-Cell Lung
27
Esophageal Neoplasms
24
Esophageal Squamous Cell Carcinoma
23
Stomach Neoplasms
19
Lung Neoplasms
19
Squamous Cell Carcinoma of Head and Neck
17
Colonic Neoplasms
17
Sarcoma
15
Pancreatic Neoplasms
15
Adenocarcinoma Of Esophagus
15
Prostatic Neoplasms
13
Neoplasm Metastasis
13
Neoplasms
12
Head and Neck Neoplasms
12
Ovarian Neoplasms
11
Carcinoma, Hepatocellular
11
Inflammatory Breast Neoplasms
9
Uterine Cervical Neoplasms
8
Urinary Bladder Neoplasms
8
Osteosarcoma
8
Fallopian Tube Neoplasms
8
Central Nervous System Neoplasms
8
Carcinoma, Intraductal, Noninfiltrating
8
Kidney Neoplasms
7
Multiple Myeloma
6
Glioblastoma
6
Carcinoma, Renal Cell
6
Interventions
Nivolumab
20
Ipilimumab
10
Paclitaxel
7
linrodostat
6
Standard of Care
6
Sirolimus
5
Gemcitabine
5
Bevacizumab
5
temsirolimus
4
relatlimab
4
Pemetrexed
4
Docetaxel
4
Carboplatin
4
ARRY-334543
4
Vorinostat
3
Erlotinib Hydrochloride
3
Dasatinib
3
Cetuximab
3
regorafenib
2
olaparib
2
apatinib
2
anlotinib
2
abemaciclib
2
Trastuzumab
2
Surveys and Questionnaires
2
Sunitinib
2
Sorafenib
2
Olanzapine
2
N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Cancer
×
Neoadjuvant Therapy
×
Clear all
NCT04257786
2020-02-06
ovarian cancer
Assiut University
Phase NA
Unknown
80 enrolled